The pharmacokinetics of cyclophosphamide in man following treatment with methotrexate

H T Mouridsen et al. Acta Pharmacol Toxicol (Copenh). 1976 May.

. 1976 May;38(5):508-12.

doi: 10.1111/j.1600-0773.1976.tb03146.x.

No abstract available

Similar articles

The pharmacokinetics of cyclophosphamide in man after treatment with allopurinol.
Witten J, Frederiksen PL, Mouridsen HT. Witten J, et al. Acta Pharmacol Toxicol (Copenh). 1980 May;46(5):392-4. doi: 10.1111/j.1600-0773.1980.tb02472.x. Acta Pharmacol Toxicol (Copenh). 1980. PMID: 7376891 No abstract available.
The effect of chloramphenicol and sulphaphenazole on the biotransformation of cyclophosphamide in man.
Faber OK, Mouridsen HT, Skovsted L. Faber OK, et al. Br J Clin Pharmacol. 1975 Jun;2(3):281-5. doi: 10.1111/j.1365-2125.1975.tb01589.x. Br J Clin Pharmacol. 1975. PMID: 791322 Free PMC article. Clinical Trial.
The biotransformation of cyclophosphamide in man: analysis of the variation in normal subjects.
Mouridsen HT, Faber O, Skovsted L. Mouridsen HT, et al. Acta Pharmacol Toxicol (Copenh). 1974 Aug;35(2):98-106. doi: 10.1111/j.1600-0773.1974.tb00729.x. Acta Pharmacol Toxicol (Copenh). 1974. PMID: 4479366 No abstract available.
The comparative pharmacology of cyclophosphamide and ifosfamide.
Colvin M. Colvin M. Semin Oncol. 1982 Dec;9(4 Suppl 1):2-7. Semin Oncol. 1982. PMID: 6761865 Review. No abstract available.
Pharmacokinetic drug interactions of commonly used anticancer drugs.
Balis FM. Balis FM. Clin Pharmacokinet. 1986 May-Jun;11(3):223-35. doi: 10.2165/00003088-198611030-00004. Clin Pharmacokinet. 1986. PMID: 2426030 Review.